CIK 0001549595
- Large accelerated filer
Nurix Therapeutics, Inc.
Sign in to watch- Ticker
- NRIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Nov 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 270838048
- Phone
- +1 415-660-5320
- Business address
- 1600 SIERRA POINT PKWY, BRISBANE, CA, 94005
- Former names
- Nurix, Inc.
- 4 Planned sale Chief Legal Officer sold 8,148 shares at $16.60 ($135,253)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale Chief Financial Officer sold 14,055 shares at an average $16.60 ($233,319)
- 4 Planned sale Chief Legal Officer sold 8,148 shares at $16.96 ($138,210)
- 4 Planned sale Chief Legal Officer sold 5,394 shares at $16.76 ($90,407)
- 4 Open-market sale Chief Financial Officer sold 2,388 shares at $16.65 ($39,749)
- 4 Open-market sale Chief Legal Officer sold 3,214 shares at $16.65 ($53,498)
- 4 Open-market sale Chief Scientific Officer sold 3,214 shares at $16.65 ($53,498)
- 4 Planned sale Chief Legal Officer sold 8,148 shares at $15.24 ($124,149)
- 4 Planned sale Chief Legal Officer sold 8,148 shares at $15.44 ($125,793)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 2 of 14 · 274 filings